Literature DB >> 33085143

Towards Dissecting the Mechanism of Protein Phosphatase-1 Inhibition by Its C-Terminal Phosphorylation.

Francesca Salvi1, Bernhard Hoermann2,3, Javier Del Pino García4, Miriam Fontanillo1, Rita Derua5,6, Monique Beullens4, Mathieu Bollen4, Orsolya Barabas7, Maja Köhn1,2,3.   

Abstract

Phosphoprotein phosphatase-1 (PP1) is a key player in the regulation of phospho-serine (pSer) and phospho-threonine (pThr) dephosphorylation and is involved in a large fraction of cellular signaling pathways. Aberrant activity of PP1 has been linked to many diseases, including cancer and heart failure. Besides a well-established activity control by regulatory proteins, an inhibitory function for phosphorylation (p) of a Thr residue in the C-terminal intrinsically disordered tail of PP1 has been demonstrated. The associated phenotype of cell-cycle arrest was repeatedly proposed to be due to autoinhibition of PP1 through either conformational changes or substrate competition. Here, we use PP1 variants created by mutations and protein semisynthesis to differentiate between these hypotheses. Our data support the hypothesis that pThr exerts its inhibitory function by mediating protein complex formation rather than by a direct mechanism of structural changes or substrate competition.
© 2020 The Authors. ChemBioChem published by Wiley-VCH GmbH.

Entities:  

Keywords:  biomimetic synthesis; peptides; phosphorylation; protein phosphatase-1 (PP1) regulation; protein semisynthesis

Year:  2020        PMID: 33085143      PMCID: PMC7984433          DOI: 10.1002/cbic.202000669

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  33 in total

1.  Phosphorylation of protein phosphatase 1 by cyclin-dependent protein kinase 5 during nerve growth factor-induced PC12 cell differentiation.

Authors:  Tong Li; Lorraine E Chalifour; Hemant K Paudel
Journal:  J Biol Chem       Date:  2007-01-03       Impact factor: 5.157

Review 2.  Flicking the switches: phosphorylation of serine/threonine protein phosphatases.

Authors:  D L Brautigan
Journal:  Semin Cancer Biol       Date:  1995-08       Impact factor: 15.707

3.  Phosphorylation and inactivation of protein phosphatase 1 by cyclin-dependent kinases.

Authors:  M Dohadwala; E F da Cruz e Silva; F L Hall; R T Williams; D A Carbonaro-Hall; A C Nairn; P Greengard; N Berndt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

4.  Interactions between a minimal protein serine/threonine phosphatase and its phosphopeptide substrate sequence.

Authors:  T Ansai; L C Dupuy; S Barik
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

5.  Mutational analysis of the catalytic subunit of muscle protein phosphatase-1.

Authors:  J Zhang; Z Zhang; K Brew; E Y Lee
Journal:  Biochemistry       Date:  1996-05-21       Impact factor: 3.162

6.  A complex of catalytically inactive protein phosphatase-1 sandwiched between Sds22 and inhibitor-3.

Authors:  Bart Lesage; Monique Beullens; Leda Pedelini; Maria Adelaida Garcia-Gimeno; Etienne Waelkens; Pascual Sanz; Mathieu Bollen
Journal:  Biochemistry       Date:  2007-07-14       Impact factor: 3.162

7.  Structure-Guided Exploration of SDS22 Interactions with Protein Phosphatase PP1 and the Splicing Factor BCLAF1.

Authors:  Ewald Heroes; Gerd Van der Hoeven; Meng S Choy; Javier Del Pino Garcia; Mónica Ferreira; Mieke Nys; Rita Derua; Monique Beullens; Chris Ulens; Wolfgang Peti; Luc Van Meervelt; Rebecca Page; Mathieu Bollen
Journal:  Structure       Date:  2019-01-17       Impact factor: 5.006

8.  Regulation of CK2 by phosphorylation and O-GlcNAcylation revealed by semisynthesis.

Authors:  Mary Katherine Tarrant; Hee-Sool Rho; Zhi Xie; Yu Lin Jiang; Christopher Gross; Jeffrey C Culhane; Gai Yan; Jiang Qian; Yoshitaka Ichikawa; Tatsuji Matsuoka; Natasha Zachara; Felicia A Etzkorn; Gerald W Hart; Jun Seop Jeong; Seth Blackshaw; Heng Zhu; Philip A Cole
Journal:  Nat Chem Biol       Date:  2012-01-22       Impact factor: 15.040

9.  Development of a peptide that selectively activates protein phosphatase-1 in living cells.

Authors:  Jayanta Chatterjee; Monique Beullens; Rasa Sukackaite; Junbin Qian; Bart Lesage; Darren J Hart; Mathieu Bollen; Maja Köhn
Journal:  Angew Chem Int Ed Engl       Date:  2012-09-07       Impact factor: 15.336

10.  Synaptic NMDA receptor stimulation activates PP1 by inhibiting its phosphorylation by Cdk5.

Authors:  Hailong Hou; Lu Sun; Benjamin A Siddoway; Ronald S Petralia; Hongtian Yang; Hua Gu; Angus C Nairn; Houhui Xia
Journal:  J Cell Biol       Date:  2013-11-04       Impact factor: 10.539

View more
  4 in total

1.  Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndrome.

Authors:  Daniel A Bonsor; Patrick Alexander; Kelly Snead; Nicole Hartig; Matthew Drew; Simon Messing; Lorenzo I Finci; Dwight V Nissley; Frank McCormick; Dominic Esposito; Pablo Rodriguez-Viciana; Andrew G Stephen; Dhirendra K Simanshu
Journal:  Nat Struct Mol Biol       Date:  2022-09-29       Impact factor: 18.361

2.  Structure of the MRAS-SHOC2-PP1C phosphatase complex.

Authors:  Zachary J Hauseman; Michelle Fodor; Anxhela Dhembi; Jessica Viscomi; David Egli; Melusine Bleu; Stephanie Katz; Eunyoung Park; Dong Man Jang; Kathryn A Porter; Fabian Meili; Hongqiu Guo; Grainne Kerr; Sandra Mollé; Camilo Velez-Vega; Kim S Beyer; Giorgio G Galli; Saveur-Michel Maira; Travis Stams; Kirk Clark; Michael J Eck; Luca Tordella; Claudio R Thoma; Daniel A King
Journal:  Nature       Date:  2022-07-13       Impact factor: 69.504

3.  miR-140-5p Aggravates Insulin Resistance via Directly Targeting GYS1 and PPP1CC in Insulin-Resistant HepG2 Cells.

Authors:  Xuemei Li; Shujun Zhao; Yan Ye; Baoli Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-04       Impact factor: 3.168

4.  Towards Dissecting the Mechanism of Protein Phosphatase-1 Inhibition by Its C-Terminal Phosphorylation.

Authors:  Francesca Salvi; Bernhard Hoermann; Javier Del Pino García; Miriam Fontanillo; Rita Derua; Monique Beullens; Mathieu Bollen; Orsolya Barabas; Maja Köhn
Journal:  Chembiochem       Date:  2020-11-17       Impact factor: 3.164

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.